Feed FMS
FM

Fresenius Medical Care

FMS · NYSE

$22.30 -2.92% (-$0.67)
1M -2.50%
Market Cap 10.8B €
P/E Ratio 11.47x
Div. Yield 3.80%
ROE 7.07%

Bulios Fair Price

$26.25

17.7% upside

Trenutna cena

$22.3

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica FMS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
8/9
Valuation
100 /100
Cheap
P/B 0.86x
P/S 0.55x
P/E 11.47x
Growth
53 /100
Stable
Book val. growth 0.69%
FCF growth 5.52%
EPS growth 43.38%
Profitability
47 /100
Moderate
FCF margin 9.11%
Op. margin 9.74%
Gross margin 26.36%
Quality
33 /100
Poor
Asset turnover 0.62x
ROA 3.00%
ROIC 5.66%
Debt
50 /100
Moderate
Net debt/EBITDA 2.89x
Int. coverage 4.88x
Debt/Equity 0.87x
Stability
87 /100
Stable
Profitable years 6
EPS volatility 37.25%
Beta 0.74x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o FMS
Online

O podjetju

Fresenius Medical Care AG & Co. KGaA (FME) is a German company specializing in providing dialysis and other medical services for patients with chronic kidney failure. Their portfolio includes a wide range of products and services in the field of dialysis, including hemodialysis, peritoneal dialysis, dialysis machines, dialysis supplies, and clinical consulting. Fresenius Medical Care focuses on providing high-quality care and innovative solutions for patients with kidney disease to improve their quality of life and health. The company also invests in research and development of new dialysis technologies and treatment methods to continuously innovate and improve its products and services. Fresenius Medical Care AG & Co. KGaA (FME) shares may be attractive to investors seeking investments in companies operating in the healthcare services field with an emphasis on caring for patients with chronic kidney failure and innovation in healthcare.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Care Facilities

CEO

Helen Giza

Employees

108,165

Headquarters

Bad Homburg

Prihajajoči dogodki

03 NOV.

Earnings

Upcoming earnings report

47d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.